Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia

scientific article published on 03 April 2018

Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0300060518760435
P698PubMed publication ID29614915

P50authorShupeng LinQ88256802
P2093author name stringSheng Ye
Chenmei Zhang
Lingfang Liang
P2860cites workBig data and clinical research: focusing on the area of critical care medicine in mainland ChinaQ28654198
Univariate description and bivariate statistical inference: the first step delving into dataQ31069141
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteriaQ33754471
Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unitQ34075262
Big data and clinical research: perspective from a clinicianQ34814449
Use of tigecycline in pediatric clinical practiceQ36342430
The epidemiology and control of Acinetobacter baumannii in health care facilitiesQ36382140
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumoniaQ36757628
Effect of Antipyretic Therapy on Mortality in Critically Ill Patients with Sepsis Receiving Mechanical Ventilation Treatment.Q37721015
Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose studyQ38477582
Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative BacteriaQ38783940
Device-associated infections in the pediatric intensive care unit at the American University of Beirut Medical Center.Q38883177
Device-associated infection rates in adult and pediatric intensive care units of hospitals in Egypt. International Nosocomial Infection Control Consortium (INICC) findings.Q39385210
Ventilator-associated pneumonia in childrenQ40293350
Retrospective analysis of tigecycline shows that it may be an option for children with severe infectionsQ40624454
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumoniaQ42905606
Pediatric acute pancreatitis related to tigecyclineQ42933420
Neutrophils engraftment delay during tigecycline treatment in 2 bone marrow-transplanted patientsQ43442285
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care settingQ43758287
Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.Q46552025
Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trialsQ47129511
All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trialsQ86502337
Confounding factors in observational study: the Achilles heelQ87441401
In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumanniiQ87454589
Observational studies using propensity score analysis underestimated the effect sizes in critical care medicineQ87770963
P433issue1
P921main subjectventilatorQ813243
P304page(s)300060518760435
P577publication date2018-04-03
P1433published inJournal of International Medical ResearchQ15758331
P1476titlePreliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia
P478volume48